Cantor Fitzgerald Initiates Coverage of Bioventus (BVS) with an Overweight Rating

finance.yahoo.com/news/cantor-fitzgerald-initiates-coverage-bioventus-133915944.html

In This Article:
Bioventus Inc. (NASDAQ:BVS) is one of the best undervalued medical device stocks to buy now. On July 7, Cantor Fitzgerald analyst Ross Osborn initiated coverage of Bioventus Inc. (NASDAQ:BVS) with an Overweight rating and $12 price target.
A doctor repairing a foot and…

This story appeared on finance.yahoo.com, 2025-07-16 13:39:15.
The Entire Business World on a Single Page. Free to Use →